An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis.

Wiesinger AM, Bigger B, Giugliani R, Lampe C, Scarpa M, Moser T, Kampmann C, Zimmermann G, Lagler FB

DOI: 10.3390/pharmaceutics15051565
Published: 2023 May 22
Container: Pharmaceutics
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics15051565,
  title = {An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis.},
  author = {Wiesinger AM and Bigger B and Giugliani R and Lampe C and Scarpa M and Moser T and Kampmann C and Zimmermann G and Lagler FB},
  year = {2023},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics15051565},
  url = {https://doi.org/10.3390/pharmaceutics15051565}
}

RIS

TY  - JOUR
TI  - An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis.
AU  - Wiesinger AM
AU  - Bigger B
AU  - Giugliani R
AU  - Lampe C
AU  - Scarpa M
AU  - Moser T
AU  - Kampmann C
AU  - Zimmermann G
AU  - Lagler FB
PY  - 2023
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics15051565
UR  - https://doi.org/10.3390/pharmaceutics15051565
ER  -

APA

AM, W., B, B., R, G., C, L., M, S., T, M., C, K., G, Z., & FB, L. (2023). An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics15051565

Source records

pubmed · retrieved 2026-09-24T18:59:01.008Z